(Q34599741)

3 August 2017

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy (English)

1 reference

3 August 2017

0 references

Bourne EJ

1

1 reference

3 August 2017

Dienstag JL

2

1 reference

3 August 2017

Lopez VA

3

1 reference

3 August 2017

Sander TJ

4

1 reference

3 August 2017

Longlet JM

5

1 reference

3 August 2017

Hall JG

6

1 reference

3 August 2017

Kwiatkowski RW

7

1 reference

3 August 2017

Wright T

8

1 reference

3 August 2017

Lai CL

9

1 reference

3 August 2017

Condreay LD

10

1 reference

3 August 2017

1 January 2007

1 reference

Journal of Viral Hepatitis

3 August 2017

1 reference

3 August 2017

14

1 reference

3 August 2017

1

1 reference

3 August 2017

55-63

1 reference

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Biochemical and genetic evidence for the hepatitis B virus replication strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Low dynamic state of viral competition in a chronic avian hepadnavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Inhibition of hepatitis B virus replication by interferon requires proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00775.X

10.1111/J.1365-2893.2006.00775.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference